Aug 21, 2017

FierceBiotech features Alexion-GNS Partnership Targeting Rare Diseases

Alexion inks genomics pacts to continue R&D reboot

August 11, 2017  – Alexion has teamed up with GNS Healthcare and Sema4 to advance its rare disease R&D agenda. The partnerships give Alexion access to modeling and simulation software used by Celgene and a partner to support its push into genomics.
Read the full article here.